Scott Darling, DO
Vascular Surgery · Liberty, MONPI 1376560714
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,940 of the $3,840 with a category attached, or 76.6%. Titan Surgical Group, LLC accounts for 78.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $2,438 and has fallen 91.6% since, to $206 in 2025. That places this record below the midpoint for vascular surgery clinicians in MO, where the typical reported total is $6,319.
Across 32 payments — averaging $120.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Titan Surgical Group, LLC$3K
- Bard Peripheral Vascular, Inc.$150
- Pfizer$134
- Medtronic$88
- Journey Medical Corporation$67
- Boston Scientific$61
- plus $342 from 12 others
What the payments were for
- Food & beverage$90023%
- Education$2,94077%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Titan Surgical Group, LLC | 5 | $2,997 |
| Bard Peripheral Vascular, Inc. | 1 | $150 |
| Pfizer | 3 | $134 |
| Medtronic | 1 | $88 |
| Journey Medical Corporation | 1 | $67 |
| Boston Scientific | 2 | $61 |
| Amgen | 2 | $48 |
| Biofrontera Inc. | 3 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Kerecis Limited | 2 | $31 |
| Lilly USA, LLC | 2 | $30 |
| Samsung HME America, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $27 |
| Biocompatibles, Inc. | 2 | $27 |
| LEO Pharma Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Smith+Nephew | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Venclose Maven Catheter$150
- LITFULO$108
How this compares
$3,840 in reported general payments places this provider in the 30th percentile of 92 vascular surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pentoxifylline | 34 | $1,096 |
| Clobetasol Propionate | 19 | $1,066 |
| Doxycycline Hyclate | 55 | $1,059 |
| Mupirocin | 121 | $780 |
| Ketoconazole | 52 | $612 |
| CiclopiroxCiclopirox Olamine | 11 | $597 |
| Triamcinolone Acetonide | 18 | $578 |
| Levocetirizine Dihydrochloride | 15 | $571 |
| Minoxidil | 25 | $460 |
| Finasteride | 22 | $307 |
| Cephalexin | 43 | $302 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $227 |
| Hydrocortisone | 14 | $114 |
| Levofloxacin | 27 | $96 |
| Ibuprofen | 20 | $67 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Liberty
- Michael DeiparineLiberty$35K
- Jeffrey JimSaint Louis$1.2M
- Karl StarkNorth Kansas City$223K
- Brian PetersonSaint Louis$216K
- Luis SanchezSaint Louis$178K
- Catherine WittgenSaint Louis$139K
- John OhmanSaint Louis$113K
- Jonathan BathColumbia$76K
- Scott KujathNorth Kansas City$72K
- Patrick GeraghtySaint Louis$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.